Tempus Labs Inc.

Three years after In Vivo identified AI in biologics as “an emerging frontier,” pharmaceutical companies are doubling down with billion-dollar partnerships and comprehensive internal platforms. Ye

SV Health Investors announced the final closing for its second Dementia Discovery Fund, DDF-2, with $269m in commitments from investors and non-profit organizations willing to put their money behind s

Biopharma financing during the fourth quarter of 2024 totaled $16.8bn from 251 deals. Of those, 60 reached $100m or more. The follow-on public offering (FOPO) and venture financing categories tied for

iRhythm Reveals Third DoJ Subpoena Wearable cardiac monitor company iRhythm Technologies, Inc. is facing a subpoena from the US Department of Justice’s Consumer Protection Branch, the company announ